Form 4 · Filed Jun 24, 2026, 01:32 AM UTC
SYRE/Spyre Therapeutics, Inc.
HENDERSON MICHAEL THOMAS — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | S | sell | 20,000 | $100 | $2,000,000 | 68,606 |
Source: SEC EDGAR raw filing ↗ · Accession 0001636282-26-000084